Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
SUNRAY-01, A Global Pivotal Study in Participants with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First-Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in those with PD-L1 expression ?50 or LY3537982 and Pembrolizumab, Pemetrexed, Platinum vs Placebo and Pembrolizumab, Pemetrexed, Platinum regardless of PD-L1 Expression
Study Type: Treatment
Phase: III
NCTID: NCT06119581
Principal Investigator:
Jun Zhang
Pilot Trial of Ultra-Hypofractionated Radiation in Early Prostate Cancer
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT03486821
Principal Investigator:
Xinglei Shen
A Phase IB Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies AIM-NIVO
PD-Inhibitor Nivolumab and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Study Type: Treatment
Phase: III
NCTID: NCT03793166
Principal Investigator:
Elizabeth Wulff-Burchfield
A Pilot Trial of Atorvastatin in p53-Mutant and p53 Wild-Type Malignancies
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT03560882
Principal Investigator:
Joaquina Baranda
CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
Study Type: Treatment
Phase: I
NCTID: NCT03507491
Principal Investigator:
Kevin Ginn
Phase II Clinical Trial of Green Tea Catechins in Men on Active Surveillance AS
Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction.
Study Type: Health Services
Phase: III
NCTID: NCT02270450
Principal Investigator:
Mazin Al-Kasspooles
Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer: Evaluation of the Optimal Dose, Safety, and Efficacy of Livmoniplimab in Combination with Budigalimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy ? LIVIGNO-4
Study Type: Treatment
Phase: II/III
NCTID: NCT06236438
Principal Investigator:
Jun Zhang